These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34517289)

  • 1. National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey.
    McAuley A; Gousias P; Hasan T; Rashid L; Richardson C; Reid G; Templeton K; McGuire J; Wise H; McVicar L; Jenks S; Gunn R; Dickson E; Stock SJ; Stockton A; Waugh C; Wood R; McMenamin J; Robertson C; Goldberg DJ; Palmateer NE
    Public Health; 2021 Oct; 199():17-19. PubMed ID: 34517289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic.
    Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A
    Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
    Sharma KA; Singh N; Hillman S; Mathur P; Yadav K; Garg A; Dadhwal V; Bhatla N
    Int J Gynaecol Obstet; 2023 Jan; 160(1):74-78. PubMed ID: 35324007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia.
    Janha RE; Bah A; Jah H; Touray F; Idris Y; Keita S; Gaye Y; Jallow S; Faye-Joof T; Njie B; Craik R; Mohammed NI; von Dadelszen P; D'Alessandro U; Roca A;
    Int J Infect Dis; 2023 Oct; 135():109-117. PubMed ID: 37586660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa.
    Sawry S; Le Roux J; Wolter N; Mbatha P; Bhiman J; Balkus J; von Gottberg A; Cohen C; Chersich M; Kekana M; Ndlovu T; Shipalana A; Mthimunye W; Patel F; Gous H; Walaza S; Tempia S; Rees H; Fairlie L
    Int J Infect Dis; 2022 Dec; 125():241-249. PubMed ID: 36347458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey.
    Hoballah A; El Haidari R; Siblany G; Abdel Sater F; Mansour S; Hassan H; Abou-Abbas L
    BMC Infect Dis; 2022 Jan; 22(1):42. PubMed ID: 35012464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
    Sharma KA
    Int J Gynaecol Obstet; 2022 Aug; 158(2):495-496. PubMed ID: 35698851
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women.
    González R; Nhampossa T; Figueroa-Romero A; Mendes A; Mazuze M; García-Otero L; Sevene E; Piqueras M; Egri N; Bedini JL; Saúte F; Menendez C
    J Acquir Immune Defic Syndr; 2023 Feb; 92(2):115-121. PubMed ID: 36287578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
    Sookaromdee P; Wiwanitkit V
    Int J Gynaecol Obstet; 2022 Aug; 158(2):494. PubMed ID: 35698856
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
    Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
    Front Public Health; 2022; 10():967447. PubMed ID: 36276377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned.
    Poljak M; Oštrbenk Valenčak A; Štrumbelj E; Maver Vodičar P; Vehovar V; Resman Rus K; Korva M; Knap N; Seme K; Petrovec M; Zupan B; Demšar J; Kurdija S; Avšič Županc T
    Clin Microbiol Infect; 2021 Jul; 27(7):1039.e1-1039.e7. PubMed ID: 33838303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 in first trimester pregnancy: a cohort study.
    la Cour Freiesleben N; Egerup P; Hviid KVR; Severinsen ER; Kolte AM; Westergaard D; Fich Olsen L; Prætorius L; Zedeler A; Christiansen AH; Nielsen JR; Bang D; Berntsen S; Ollé-López J; Ingham A; Bello-Rodríguez J; Storm DM; Ethelberg-Findsen J; Hoffmann ER; Wilken-Jensen C; Jørgensen FS; Westh H; Jørgensen HL; Nielsen HS
    Hum Reprod; 2021 Jan; 36(1):40-47. PubMed ID: 33145598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
    Duong S; Burtniak J; Gretchen A; Mai A; Klassen P; Wei Y; Loeppky C; Shaw SY; Bullard J; Van Caeseele P; Stein DR
    BMC Public Health; 2023 Dec; 23(1):2420. PubMed ID: 38053033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.
    Tunheim G; Rø GØI; Tran T; Kran AB; Andersen JT; Vaage EB; Kolderup A; Vaage JT; Lund-Johansen F; Hungnes O
    Influenza Other Respir Viruses; 2022 Mar; 16(2):204-212. PubMed ID: 34751488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil.
    de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Grespan R; de Souza Siqueira Quintans J; Dos Santos DM; da Silva DN; de Oliveira YLM; de Franca MNF; da Conceição Silva M; de Sá DLF; de Carvalho FO; de Souza MF; de Oliveira Góes MA; Santos VS; Martins-Filho PR
    Pathog Glob Health; 2023 Jul; 117(5):505-512. PubMed ID: 36094065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring SARS-CoV-2 seroprevalence over time among pregnant women admitted to delivery units: Suitability for surveillance.
    Miyadahira MY; Brizot ML; Alexander N; Cerdeira Sabino E; Campos de Oliveira da Silva L; Hoshida MS; da Silva Sousa Oliveira AM; Silva Farche AC; Pulcineli Vieira Francisco R; Mayaud P
    PLoS One; 2023; 18(1):e0280109. PubMed ID: 36603011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.